Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
4.12.22-Health-Science-Feng Zhang
Conference Video
|
Duration: 35:56
April 12, 2022
View this past event
Preview
4.12.22-Health-Science-Feng Zhang
Please
login
to view this video.
Video details
Many powerful molecular biology tools have their origin in nature, and, often, microbial life. From restriction enzymes to CRISPR-Cas9, microbes utilize a diverse array of systems to get ahead evolutionarily. We are interested in exploring this natural diversity through bioinformatics, biochemical, and molecular work to better understand the fundamental ways in which living organisms sense and respond to their environment and ultimately to harness these systems to improve human health. Building on our demonstration that Cas9 can be repurposed for precision genome editing in mammalian cells, we began looking for novel CRISPR-Cas systems that may have other useful properties. This led to the discovery of several new CRISPR systems, including the CRISPR-Cas13 family that target RNA, rather than DNA. We developed a toolbox for RNA modulation based on Cas13, including methods for precision base editing. We are expanding our biodiscovery efforts to search for new microbial proteins that may be adapted for applications beyond genome and transcriptome modulation, capitalizing on the growing volume of microbial genomic sequences and building on our bioengineering expertise. We are particularly interested in identifying new therapeutic modalities and vehicles for delivering cellular and molecular cargo. We hope that this combination of tools and delivery modes will accelerate basic research into human disease and open up new therapeutic possibilities.
Locked Interactive transcript
Please
login
to view this video.
Video details
Many powerful molecular biology tools have their origin in nature, and, often, microbial life. From restriction enzymes to CRISPR-Cas9, microbes utilize a diverse array of systems to get ahead evolutionarily. We are interested in exploring this natural diversity through bioinformatics, biochemical, and molecular work to better understand the fundamental ways in which living organisms sense and respond to their environment and ultimately to harness these systems to improve human health. Building on our demonstration that Cas9 can be repurposed for precision genome editing in mammalian cells, we began looking for novel CRISPR-Cas systems that may have other useful properties. This led to the discovery of several new CRISPR systems, including the CRISPR-Cas13 family that target RNA, rather than DNA. We developed a toolbox for RNA modulation based on Cas13, including methods for precision base editing. We are expanding our biodiscovery efforts to search for new microbial proteins that may be adapted for applications beyond genome and transcriptome modulation, capitalizing on the growing volume of microbial genomic sequences and building on our bioengineering expertise. We are particularly interested in identifying new therapeutic modalities and vehicles for delivering cellular and molecular cargo. We hope that this combination of tools and delivery modes will accelerate basic research into human disease and open up new therapeutic possibilities.
Locked Interactive transcript
More Videos From This Event
See all videos
April 2022
|
Conference Video
4.12.22-Health-Science-Eric-Smith
DFCI: The Challenges and Opportunities in Cell and Gene Therapy
April 2022
|
Conference Video
4.12.22-Health-Science-Deepak-Mishra
Synthetic Gene Networks for Multi-step Differentiation of Stem Cells into Programmable Organoids
April 2022
|
Conference Video
4.12.22-Health-Science-Ran-Zheng
Unlocking the Potential of Life Sciences Innovation by Harnessing the Power of Mission-driven Collaborations
April 2022
|
Conference Video
4.12.22-Health-Science-Parisa-Yousefpour
Self-Replicating RNA Technologies for Vaccines and Cancer Immunotherapy
April 2022
|
Conference Video
4.12.22-Health-Science-Jongyoon-Han
Label-Free Biophysical Critical Quality Attributes (CQAs) for Cell Therapy Products
April 2022
|
Conference Video
4.12.22-Health-Science-Jianzhu-Chen
CAR-NK Cell Therapies for Cancer
April 2022
|
Conference Video
4.12.22-Health-Science-Braatz-Nguyen
Rational Design of rAAV Production via Mechanistic Modeling
April 2022
|
Conference Video
4.12.22-Health-Science-Michael-Birnbaum
Reprogramming adaptive immunity
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Kytopen
Kytopen
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Cellino
Cellino
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Tevard-Biosciences
Tevard Biosciences
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Multiply-Labs
Multiply Labs
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Kano-Therapeutics
Kano Therapeutics
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Volta-Labs
Volta Labs
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-CellChorus
CellChorus
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Fathom-Data
Fathom Data